Skip to content

Autonomic and Peripheral Neurochemical Responses to Maximal Rowing Exercise

Integrated Autonomic, Neuroendocrine and Peripheral Neurochemical Responses to Maximal Rowing Exercise and Early Recovery in Elite Athletes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07661953
Enrollment
15
Registered
2026-06-22
Start date
2024-06-06
Completion date
2025-03-03
Last updated
2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healhty

Keywords

maximal exercise, elite athletes, heart rate variability, autonomic recovery, Task Force Monitor, cortisol, testosterone, dopamine, serotonine, GABA, neuroendocrine response, exercise recovery

Brief summary

The goal of this observational study is to characterize autonomic, neuroendocrine, and peripheral neurochemical responses to maximal rowing exercise and early recovery in highly trained male athletes. The main questions it aims to answer are: * How do circulating concentrations of cortisol, testosterone, dopamine, serotonin, gamma-aminobutyric acid (GABA), and the testosterone-to-cortisol ratio change in response to maximal rowing exercise and during the first hour of recovery? * How do autonomic cardiovascular parameters, including heart rate variability, blood pressure variability, and baroreflex sensitivity, change 3 hours after maximal exercise compared with baseline values? * Do endocrine, peripheral neurochemical, and autonomic responses demonstrate similar or divergent recovery patterns following maximal exercise? Participants will: * Perform a maximal 6,000-m rowing ergometer test. * Undergo venous blood sampling before exercise, immediately after exercise, and 1 hour after exercise recovery for assessment of endocrine and peripheral neurochemical markers. * Undergo noninvasive cardiovascular and autonomic assessment using the Task Force Monitor System before exercise and 3 hours after exercise recovery.

Detailed description

This observational study was conducted to investigate physiological responses to maximal rowing exercise and subsequent recovery in highly trained male athletes. The study employed a repeated-measures design, allowing assessment of exercise-induced changes across multiple physiological systems during distinct phases of recovery. Participants completed a maximal 6,000-m rowing ergometer test under standardized laboratory conditions. Biological and physiological measurements were collected before exercise and during recovery according to a predefined protocol. Venous blood samples were obtained at baseline, immediately after exercise, and after 1 hour of recovery. Noninvasive autonomic and cardiovascular assessments were performed using the Task Force Monitor System before exercise and after 3 hours of recovery. The protocol was designed to capture both immediate biochemical responses and delayed autonomic recovery following maximal exercise. The study focused on endocrine, peripheral neurochemical, and autonomic cardiovascular regulation. Peripheral neurochemical markers were assessed from blood samples and interpreted as components of the peripheral physiological response to exercise rather than direct indicators of central nervous system activity. Data collection was performed under controlled laboratory conditions using standardized procedures. All measurements were obtained by trained investigators using calibrated equipment. Data quality was verified through routine review of laboratory and physiological recordings. Implausible values and technical artifacts were identified and evaluated before statistical analysis. The planned sample size was based on the availability of elite athletes meeting the inclusion criteria and the repeated-measures design of the study. Statistical analyses were conducted using repeated-measures approaches appropriate for longitudinal within-subject data. Data distribution was assessed prior to analysis. Parametric or non-parametric tests were applied as appropriate. Effect sizes were calculated to complement significance testing. Associations between selected physiological variables were explored using correlation analyses. Missing data were handled using complete-case analysis, with no imputation procedures applied.

Interventions

OTHERMaximal 6,000-m rowing ergometer test

Participants completed a single maximal 6,000-m rowing ergometer test. The intervention was distinguished by a standardized all-out rowing protocol combined with peripheral blood sampling before exercise, immediately after exercise, and after 1 hour of recovery, as well as noninvasive autonomic and cardiovascular assessment at baseline and 3 hours after exercise.

Sponsors

Poznan University of Physical Education
Lead SponsorOTHER
Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Highly trained rowers competing at the national or international level * Regular participation in structured rowing training * Current sports medical clearance for maximal exercise testing * Ability to complete a maximal 6,000-m rowing ergometer test * Written informed consent to participate in the study

Exclusion criteria

* Acute illness, infection, or injury before testing * Diagnosed cardiovascular, metabolic, neurological, endocrine, or inflammatory disorder * Use of medications or supplements that could affect cardiovascular, endocrine, metabolic, or neurochemical responses * Inability to complete the maximal 6,000-m rowing ergometer test * Inability or refusal to provide blood samples * Non-compliance with study procedures or pre-test instructions

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in serum cortisol concentrationBaseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Marker of hypothalamic-pituitary-adrenal axis activation and exercise-induced endocrine response.
Change from baseline in serum testosterone concentrationBaseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Marker of anabolic status and exercise-induced endocrine response.
Change from baseline in testosterone-to-cortisol ratio (T/C)Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Marker of anabolic-catabolic balance during exercise and recovery.
Change from baseline in serum dopamine concentrationBaseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Peripheral neurochemical marker associated with physiological responses to exercise and recovery.
Change from baseline in serum serotonin concentrationBaseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Peripheral neurochemical marker associated with exercise-induced physiological responses and recovery processes.
Change from baseline in serum gamma-aminobutyric acid (GABA) concentrationBaseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Peripheral neurochemical marker involved in physiological regulatory processes during exercise and recovery.
Change from baseline in systolic blood pressure (sBP)Baseline (pre-exercise) and 180 minutes post-exercise.Continuous beat-to-beat systolic blood pressure measured using the Task Force Monitor System.
Change from baseline in diastolic blood pressure (dBP)Baseline (pre-exercise) and 180 minutes post-exercise.Continuous beat-to-beat diastolic blood pressure measured using the Task Force Monitor System.
Change from baseline in mean blood pressure (mBP)Baseline (pre-exercise) and 180 minutes post-exercise.Continuous beat-to-beat mean arterial pressure measured using the Task Force Monitor System.
Change from baseline in heart rate (HR)Baseline (pre-exercise) and 180 minutes post-exercise.Heart rate derived from continuous electrocardiographic recordings.
Change from baseline in total power spectral density of RR intervals (PSD-RRI)Baseline (pre-exercise) and 180 minutes post-exercise.Total spectral power of heart rate variability obtained from power spectral analysis of RR intervals.
Change from baseline in low-frequency power of RR intervals (LF-RRI)Baseline (pre-exercise) and 180 minutes post-exercise.Low-frequency component of heart rate variability (0.04-0.15 Hz), reflecting combined sympathetic and parasympathetic modulation.
Change from baseline in high-frequency power of RR intervals (HF-RRI)Baseline (pre-exercise) and 180 minutes post-exercise.High-frequency component of heart rate variability (0.17-0.40 Hz), considered an indicator of parasympathetic modulation.
Change from baseline in LF/HF ratioBaseline (pre-exercise) and 180 minutes post-exercise.Ratio of low-frequency to high-frequency spectral power used as an index of sympathovagal balance.
Change from baseline in baroreflex sensitivity (BRS)Baseline (pre-exercise) and 180 minutes post-exercise.Index of baroreflex function calculated using the spontaneous sequence method.
Change from baseline in baroreflex effectiveness index (BEI)Baseline (pre-exercise) and 180 minutes post-exercise.Index quantifying the effectiveness of baroreflex-mediated cardiovascular regulation.

Secondary

MeasureTime frameDescription
Change from baseline in blood lactate concentrationBaseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.Marker of metabolic response to maximal rowing exercise and early recovery.

Countries

Poland

Contacts

STUDY_CHAIRAnna Skarpańska-Stejnborn, Professor

Poznan University of Physical Education, Gorzów Wielkopolski; Faculty of Sport Sciences in Gorzów Wielkopolski;

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 19, 2026